Immunic reports positive interim data from phase 2 calliper trial of vidofludimus calcium in progressive multiple sclerosis
– 24-week data from first half of patients shows improvements in biomarker nfl, consistent throughout the overall progressive multiple sclerosis population as well as all subtypes – – nfl effect in non-active subpopulation reinforces vidofludimus calcium's neuroprotective potential – – brain volume data of the full 467 calliper patient cohort expected in april 2025 – – phase 3 ensure program in relapsing multiple sclerosis ongoing – – conference call and webcast to be held tomorrow, october 10, 2023 at 8:00 am et – new york , oct. 9, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced positive interim data from its phase 2 calliper trial of nuclear receptor related 1 (nurr1) activator, vidofludimus calcium (imu-838), in patients with progressive multiple sclerosis (pms). the company believes that this data shows biomarker evidence that vidofludimus calcium's activity extends beyond the previously observed anti-inflammatory effects, thereby further reinforcing its neuroprotective potential.
IMUX Ratings Summary
IMUX Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission